March/April 2013

The clinical and business aspects of medicine traditionally have been seen as polar opposites, with MDs monitoring the health of the patient and MBAs taking the fiscal pulse of the institution. More and more, though, cardiologists have turned to additional education to become adept at both, a trend that broadens their opportunities and also may benefit peers and patients.

EHRs lighten administrative burden, but practices must roll out implementation carefully and anticipate bumps in the road.

Coronary CT angiography (CCTA) made a splash in the mid-2000s with cardiologists and radiologists when it was shown to effectively detect coronary stenosis.

TAVR aortic stenosis aortic valve structural heart disease

Researchers evaluate how patient characteristics, procedural approach and devices impact transcatheter aortic valve replacement (TAVR) outcomes.

Cardiac imaging equipment doesn’t always pay for itself anymore. What should providers do about that aging suite?

An administrator and two cath lab directors share tips on how to preserve good will and restore a damaged reputation.

In November 2009, Cardiovascular Business asked if the much-anticipated FREEDOM trial would “set us free” by better informing decisions to treat high-risk diabetics with multivessel disease using either PCI or CABG.

Decreasing in-hospital cardiac morbidity and mortality is attainable and should be part of quality improvement efforts, researchers say.

In this issue of Cardiovascular Business, we examine the growing trend of MD/MBAs. Traditionally, physicians who chose this path first earned their MD, practiced for several years and then pursued an MBA. While a handful of MD/MBA dual-degree programs existed two decades ago, the numbers have reached an estimated 65 today.

The American College of Cardiology's (ACC) clinical resources, educational programming, patient education tools and a suite of hospital and outpatient registries are among the offerings that members say are of the most value.

Select an Issue
""